Clinical Trial Update: A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa [Phase 1, Phase 2]

View source ↗

Summary

Results from a completed Phase 1b/2 trial evaluate the safety and microbiological activity of a bacteriophage therapy in cystic fibrosis patients colonized with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Disease Carrier, Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED